Tushar Mahajan Of Nomura On Indian Markets & More.

  • 9 years ago
Tushar Mahajan, Head of Derivatives at Nomura believes that India is cautious on the Pharma sector. He also adds that the PSB space will give good returns on investments. Tune in to know more.

Recommended